← Back to guidelines
Cardiology143 papers

Relapsing polychondritis

Last edited: 4/14/2026

Overview

Relapsing polychondritis (RP) is an uncommon autoimmune disorder characterized by recurrent inflammation primarily affecting cartilaginous structures, including the nose, ears, airways, and joints, but also impacting non-cartilage organs like blood vessels, skin, inner ear, and eyes 12.

Diagnosis

  • Key Clinical Features: Nasal bridge chondritis, auricular chondritis, ocular inflammation, bronchial tree involvement 2.
  • Recommended Tests:
  • - Imaging (e.g., CT, MRI) to assess organ involvement 1. - Laboratory tests for inflammatory markers (ESR, CRP) 1. - (18)F-FDG PET-CT for diagnosis, targeted biopsy, and monitoring disease activity 4.
  • Diagnostic Criteria: No universally accepted criteria; diagnosis often relies on clinical presentation and exclusion of other conditions 2.
  • Management

  • First-Line Treatments:
  • - Corticosteroids (dose varies; typically high initial doses for acute flares) 37.
  • Adjunctive Treatments:
  • - Immunosuppressive agents (e.g., methotrexate, azathioprine) for maintenance therapy 3. - Biologic agents (e.g., TNF inhibitors) in refractory cases 3.
  • Specific Interventions:
  • - Thoracic epidural morphine for intractable chest wall pain 7. - Surgical interventions for severe complications like valvular insufficiency 10.

    Special Populations

  • Pregnancy: Limited data; management requires careful monitoring and individualized treatment plans 3.
  • Comorbidities: Patients with associated conditions like familial Mediterranean fever may require tailored management strategies 5.
  • Key Recommendations

  • Utilize (18)F-FDG PET-CT for accurate diagnosis and monitoring of disease activity in relapsing polychondritis (Evidence: Moderate) 4.
  • Initiate high-dose corticosteroids for acute flares and consider immunosuppressive therapy for maintenance to prevent relapses (Evidence: Expert opinion) 3.
  • Tailor pain management strategies, including thoracic epidural analgesia, for patients with severe chest wall pain (Evidence: Weak) 7.
  • Closely monitor and manage cardiac involvement, particularly valvular insufficiency, with potential surgical intervention if necessary (Evidence: Moderate) 10.
  • References

    1 Mertz P, Sparks J, Kobrin D, Ogbonnaya SA, Sevim E, Michet C et al.. Relapsing polychondritis: Best Practice & Clinical Rheumatology. Best practice & research. Clinical rheumatology 2023. link 2 Kingdon J, Roscamp J, Sangle S, D'Cruz D. Relapsing polychondritis: a clinical review for rheumatologists. Rheumatology (Oxford, England) 2018. link 3 Smylie A, Malhotra N, Brassard A. Relapsing Polychondritis: A Review and Guide for the Dermatologist. American journal of clinical dermatology 2017. link 4 Lei W, Zeng H, Zeng DX, Zhang B, Zhu YH, Jiang JH et al.. (18)F-FDG PET-CT: a powerful tool for the diagnosis and treatment of relapsing polychondritis. The British journal of radiology 2016. link 5 Miller EB, Friedman JA, Lahav Y, Landau Z. Relapsing polychondritis and familial Mediterranean fever--an association. Clinical rheumatology 2011. link 6 Michet CJ. Vasculitis and relapsing polychondritis. Rheumatic diseases clinics of North America 1990. link 7 Waldman SD, Cronen MC. Thoracic epidural morphine in the palliation of chest wall pain secondary to relapsing polychondritis. Journal of pain and symptom management 1989. link90063-8) 8 Schlapbach P, Gerber NJ, Ramser P, van't Hooft FM. Relapsing polychondritis mimicking rheumatoid arthritis. Annals of the rheumatic diseases 1988. link 9 Hayward AW, al-Shaikh B. Relapsing polychondritis and the anaesthetist. Anaesthesia 1988. link 10 Balsa-Criado A, Garcia-Fernandez F, Roldan I. Cardiac involvement in relapsing polychondritis. International journal of cardiology 1987. link90214-2) 11 Weinberger A, Myers AR. Relapsing polychondritis associated with cutaneous vasculitis. Archives of dermatology 1979. link

    Original source

    1. [1]
      Relapsing polychondritis: Best Practice & Clinical Rheumatology.Mertz P, Sparks J, Kobrin D, Ogbonnaya SA, Sevim E, Michet C et al. Best practice & research. Clinical rheumatology (2023)
    2. [2]
      Relapsing polychondritis: a clinical review for rheumatologists.Kingdon J, Roscamp J, Sangle S, D'Cruz D Rheumatology (Oxford, England) (2018)
    3. [3]
      Relapsing Polychondritis: A Review and Guide for the Dermatologist.Smylie A, Malhotra N, Brassard A American journal of clinical dermatology (2017)
    4. [4]
      (18)F-FDG PET-CT: a powerful tool for the diagnosis and treatment of relapsing polychondritis.Lei W, Zeng H, Zeng DX, Zhang B, Zhu YH, Jiang JH et al. The British journal of radiology (2016)
    5. [5]
      Relapsing polychondritis and familial Mediterranean fever--an association.Miller EB, Friedman JA, Lahav Y, Landau Z Clinical rheumatology (2011)
    6. [6]
      Vasculitis and relapsing polychondritis.Michet CJ Rheumatic diseases clinics of North America (1990)
    7. [7]
      Thoracic epidural morphine in the palliation of chest wall pain secondary to relapsing polychondritis.Waldman SD, Cronen MC Journal of pain and symptom management (1989)
    8. [8]
      Relapsing polychondritis mimicking rheumatoid arthritis.Schlapbach P, Gerber NJ, Ramser P, van't Hooft FM Annals of the rheumatic diseases (1988)
    9. [9]
      Relapsing polychondritis and the anaesthetist.Hayward AW, al-Shaikh B Anaesthesia (1988)
    10. [10]
      Cardiac involvement in relapsing polychondritis.Balsa-Criado A, Garcia-Fernandez F, Roldan I International journal of cardiology (1987)
    11. [11]
      Relapsing polychondritis associated with cutaneous vasculitis.Weinberger A, Myers AR Archives of dermatology (1979)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG